Workflow
白云山: 广州白云山医药集团股份有限公司第九届董事会第二十六次会议决议公告
Zheng Quan Zhi Xing·2025-06-23 16:31

Group 1 - The board of directors of Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. held its 26th meeting of the 9th session on June 23, 2025, with all 9 directors participating and voting [1][2] - The meeting approved the proposal to add new members to the specialized committees of the board, with a unanimous vote of 9 in favor, 0 against, and 0 abstentions [1] - The newly appointed members to the specialized committees include Mr. Li Xiaojun, Mr. Cheng Hongjin, and Mr. Tang Heping, effective from the date of the board's approval until the end of the current board's term [1][2] Group 2 - The composition of the Strategic Development and Investment Committee now includes Mr. Li Xiaojun as the chairperson and members Mr. Li Hong, Mr. Chen Yajin, and Ms. Sun Baoqing [1] - The Nomination and Remuneration Committee is chaired by Mr. Huang Min, with members including Mr. Chen Yajin, Ms. Sun Baoqing, and the newly added Mr. Cheng Hongjin [2] - The Budget Committee is chaired by Mr. Chen Yajin, with members including Ms. Cheng Ning, Mr. Huang Min, Mr. Huang Longde, and the newly added Mr. Tang Heping [2]